Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Oct 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.68 | 10,000 | 26.80 k | 44,730 |
20 Jun 24 | APRE Aprea Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 1,045 | 0.00 | 34,730 |
20 Jun 24 | APRE Aprea Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 4.07 | 4,185 | 17.03 k | 4,185 |
13 Mar 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 7.29 | 6,860 | 50.01 k | 33,685 |
13 Mar 24 | APRE Aprea Therapeutics | Tranche B Warrant Common Stock | Buy | Acquire P | No | No | 0 | 3,430 | 0.00 | 3,430 |
13 Mar 24 | APRE Aprea Therapeutics | Tranche A Warrant Common Stock | Buy | Acquire P | No | No | 0 | 3,430 | 0.00 | 3,430 |
5 Feb 24 | APTO Aptose Biosciences | Director Stock Option Common Shares | Grant | Acquire A | No | No | 2 | 3,333 | 6.67 k | 3,333 |
22 Sep 23 | APTO Aptose Biosciences | Common Shares | Buy | Acquire P | No | No | 3.14 | 17,000 | 53.38 k | 17,000 |